Combination of a sodium-proton exchanger inhibitor and of a dihydro1,3,5-triazine amine derivative

Details for Australian Patent Application No. 2010272926 (hide)

Owner Merck Patent GmbH

Inventors Mesangeau, Didier; Cravo, Daniel; Leverve, Xavier

Agent Davies Collison Cave

Pub. Number AU-A-2010272926

PCT Pub. Number WO2011/006573

Priority 0954978 17.07.09 FR

Filing date 18 June 2010

Wipo publication date 20 January 2011

International Classifications

A61K 31/53 (2006.01) - having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine

A61K 31/155 (2006.01) - Amidines (), e.g. guanidine (HNC(NH)NH), isourea (HNC(OH)NH), isothiourea (HNC(SH)NH)

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

8 March 2012 PCT application entered the National Phase

  PCT publication WO2011/006573 Priority application(s): WO2011/006573

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010272931-A cooking oven with at least one convection heating device

2010272922-Heterocyclic compounds as autotaxin inhibitors